CD209 signaling pathway as a biomarker for cisplatin chemotherapy response in small cell lung cancer

您当前的位置：

首页 >

文章列表页 >

CD209 signaling pathway as a biomarker for cisplatin chemotherapy response in small cell lung cancer

Editorial | 更新时间：2024-02-04

- CD209 signaling pathway as a biomarker for cisplatin chemotherapy response in small cell lung cancer
- CD209 signaling pathway as a biomarker for cisplatin chemotherapy response in small cell lung cancer
- Genes & Diseases 2024年11卷第3期
- 作者机构：
  
  Department of Oncology, Zhujiang Hospital, Southern Medical University,Guangdong,Guangzhou,China,510282
- 作者简介：
- 基金信息：
- DOI：10.1016/j.gendis.2023.06.011
  中图分类号：
- 纸质出版日期：2024，
  
  网络出版日期：2024-5-1，
扫描看全文
Anqi Lin, Hong Yang, Jian Zhang, 等. CD209 signaling pathway as a biomarker for cisplatin chemotherapy response in small cell lung cancer[J]. Genes & Diseases, 2024,11(3).

Anqi Lin, Hong Yang, Jian Zhang, et al. CD209 signaling pathway as a biomarker for cisplatin chemotherapy response in small cell lung cancer[J]. Genes & Diseases, 2024,11(3).
Anqi Lin, Hong Yang, Jian Zhang, 等. CD209 signaling pathway as a biomarker for cisplatin chemotherapy response in small cell lung cancer[J]. Genes & Diseases, 2024,11(3). DOI： 10.1016/j.gendis.2023.06.011.

Anqi Lin, Hong Yang, Jian Zhang, et al. CD209 signaling pathway as a biomarker for cisplatin chemotherapy response in small cell lung cancer[J]. Genes & Diseases, 2024,11(3). DOI： 10.1016/j.gendis.2023.06.011.

摘要

Abstract

关键词

Keywords

references

0

浏览量

0

下载量

0

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

相关文章

暂无数据

相关作者

暂无数据

相关机构

暂无数据

⁰